← Dashboard
Stock
HCA
HCA Healthcare, Inc.Health CareHealth Care FacilitiesLatest close $4237 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
7
27 funds tracked
Ever held
16
Current + past
New this quarter
1
Exited this quarter
0
Marquee-fund ownership over time
Aug 14, 2013Feb 13, 2018May 15, 2023May 15, 2026
Now
7
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Viking Global Investors re-entered | Q4 2013 | 51Q | $43 | $423 | +893% |
| Bridgewater Associates | Q2 2020 | 25Q | $95 | $423 | +347% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $367 | $423 | +15% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $367 | $423 | +15% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $367 | $423 | +15% |
| Millennium Management re-entered | Q3 2024(8Q snapshot) | 7Q | $367 | $423 | +15% |
| Two Sigma Investments re-entered | Q4 2024(8Q snapshot) | 6Q | $342 | $423 | +24% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Scion Asset Management 3× in & out | Q1 2025 | Q2 2025 | → $383 | +22% |
| Glenview Capital | Q3 2013 | Q4 2024 | → $342 | +841% |
| Renaissance Technologies | Q3 2024 | Q4 2024 | → $345 | -3% |
| Appaloosa 4× in & out | Q1 2024 | Q2 2024 | → $322 | +7% |
| Maverick Capital 8× in & out | Q3 2023 | Q1 2024 | → $300 | +13% |
| Third Point | Q2 2023 | Q4 2023 | → $233 | -14% |
| Elliott Management | Q1 2017 | Q2 2017 | → $78 | +0% |
| Lone Pine Capital 2× in & out | Q4 2016 | Q1 2017 | → $78 | +16% |
| Duquesne Family Office | Q3 2014 | Q4 2014 | → $58 | -6% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at HCA Healthcare, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
9
Filings · last 90d
24
Total on file
671
Recent SEC buffer
Most recent
May 11, 2026
30d / 90d windows measured from May 11, 2026 — the most recent Form 4 on file — not from today.
- Form 40001193125-26-217167May 11, 2026
- Form 40001140361-26-018355Apr 30, 2026
- Form 40001140361-26-018352Apr 30, 2026
- Form 40001193125-26-197781Apr 30, 2026
- Form 40001193125-26-197773Apr 30, 2026
- Form 40001193125-26-197763Apr 30, 2026
- Form 40001193125-26-197757Apr 30, 2026
- Form 40001193125-26-197746Apr 30, 2026
- Form 40001193125-26-197734Apr 30, 2026
- Form 40001193125-26-057701Feb 18, 2026
- Form 40001193125-26-049224Feb 12, 2026
- Form 40001193125-26-049221Feb 12, 2026
- Form 40001193125-26-049217Feb 12, 2026
- Form 40001193125-26-049208Feb 12, 2026
- Form 40001193125-26-049200Feb 12, 2026
Showing 15 of 671 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · HCA Healthcare, Inc.Annual figures sourced directly from HCA Healthcare, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$75.6B
FY2025+7% YoY
Net income
$6.78B
FY2025+18% YoY
EPS (diluted)
$28.33
FY2025+29% YoY
Free cash flow(?)
$7.69B
FY2025+36% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for HCA Healthcare, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventApr 30, 2026
- 10-QQuarterly reportApr 29, 2026
- 8-KMaterial eventApr 28, 2026
- 8-KMaterial eventApr 27, 2026
- 8-KMaterial eventApr 24, 2026
- DEF 14AProxy statementMar 13, 2026
- 8-KMaterial eventFeb 25, 2026
- 10-KAnnual reportFeb 10, 2026
- 8-KMaterial eventJan 27, 2026
- 8-KMaterial eventOct 31, 2025
- 10-QQuarterly reportOct 30, 2025
- 8-KMaterial eventOct 27, 2025
- 8-KMaterial eventOct 24, 2025
- 10-QQuarterly reportAug 4, 2025
- 8-KMaterial eventJul 25, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Two Sigma Investments | Q2 2026 | open | $423 | $423 | -0% |
| Citadel Advisors | Q4 2025 | open | $471 | $423 | -10% |
| Millennium Management | Q3 2025 | open | $392 | $423 | +8% |
| Scion Asset Management | Q1 2025 | Q2 2025 | $313 | $383 | +22% |
| Two Sigma Investments | Q4 2024 | Q1 2026 | $342 | $534 | +56% |
| Citadel Advisors | Q3 2024 | Q2 2025 | $367 | $383 | +4% |
| D.E. Shaw | Q3 2024 | open | $367 | $423 | +15% |
| AQR Capital Management | Q3 2024 | open | $367 | $423 | +15% |
| Millennium Management | Q3 2024 | Q2 2025 | $367 | $383 | +4% |
| Renaissance Technologies | Q3 2024 | Q4 2024 | $356 | $345 | -3% |
| Appaloosa | Q1 2024 | Q2 2024 | $300 | $322 | +7% |
| Viking Global Investors | Q1 2024 | open | $300 | $367 | +22% |
| Scion Asset Management | Q1 2024 | Q3 2024 | $300 | $367 | +22% |
| Maverick Capital | Q3 2023 | Q1 2024 | $265 | $300 | +13% |
| Third Point | Q2 2023 | Q4 2023 | $271 | $233 | -14% |
| Appaloosa | Q3 2022 | Q3 2023 | $210 | $265 | +26% |
| Maverick Capital | Q2 2022 | Q1 2023 | $205 | $252 | +23% |
| Viking Global Investors | Q1 2021 | Q3 2021 | $166 | $237 | +42% |
| Appaloosa | Q2 2020 | Q1 2022 | $94 | $227 | +141% |
| Bridgewater Associates | Q2 2020 | open | $95 | $367 | +287% |
| Maverick Capital | Q4 2019 | Q1 2022 | $128 | $227 | +78% |
| Maverick Capital | Q2 2019 | Q3 2019 | $116 | $116 | +0% |
| Maverick Capital | Q2 2018 | Q3 2018 | $94 | $121 | +29% |
| Elliott Management | Q1 2017 | Q2 2017 | $78 | $78 | +0% |
| Maverick Capital | Q1 2017 | Q1 2018 | $78 | $92 | +18% |
| Lone Pine Capital | Q4 2016 | Q1 2017 | $67 | $78 | +16% |
| Viking Global Investors | Q3 2016 | Q4 2016 | $72 | $67 | -7% |
| Maverick Capital | Q2 2016 | Q3 2016 | $72 | $72 | -1% |
| Appaloosa | Q2 2016 | Q3 2018 | $72 | $121 | +68% |
| Scion Asset Management | Q1 2016 | Q1 2019 | $61 | $134 | +119% |
| Lone Pine Capital | Q1 2015 | Q4 2015 | $64 | $62 | -3% |
| Viking Global Investors | Q4 2014 | Q3 2015 | $58 | $85 | +45% |
| Duquesne Family Office | Q3 2014 | Q4 2014 | $62 | $58 | -6% |
| Viking Global Investors | Q4 2013 | Q2 2014 | $43 | $48 | +14% |
| Glenview Capital | Q3 2013 | Q4 2024 | $36 | $342 | +841% |
| Maverick Capital | Q3 2013 | Q3 2015 | $36 | $85 | +134% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.